Paul A. Corris

Paul A. Corris's AcademicInfluence.com Rankings

Paul A. Corris

Philosophy

#7713

World Rank

#10963

Historical Rank

Logic

#4751

World Rank

#6078

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul A. Corris Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul A. Corris's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the diagnosis and treatment of pulmonary hypertension (2009) (1630)
Inhaled iloprost for severe pulmonary hypertension. (2002) (1369)
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. (1998) (1126)
A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. (2015) (1049)
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family (2000) (732)
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. (2005) (697)
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. (2009) (615)
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. (2001) (552)
Asthma control during the year after bronchial thermoplasty. (2007) (549)
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. (2012) (490)
A new classification system for chronic lung allograft dysfunction. (2014) (450)
[Updated treatment algorithm of pulmonary arterial hypertension]. (2014) (421)
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome (2014) (420)
Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. (2007) (396)
International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). (1998) (392)
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. (2019) (382)
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. (2008) (309)
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. (2017) (304)
Updated treatment algorithm of pulmonary arterial hypertension. (2013) (272)
Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. (2001) (260)
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. (2004) (248)
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort (2016) (248)
Interventional and surgical modalities of treatment in pulmonary hypertension. (2009) (245)
Whole-genome sequencing of patients with rare diseases in a national health system (2020) (239)
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (238)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis (2015) (228)
Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. (2005) (222)
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension (2006) (218)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary (2015) (200)
Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial (2011) (185)
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension (2008) (183)
Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome (2008) (169)
Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. (2007) (168)
Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. (2000) (164)
Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. (1993) (160)
Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis (2001) (155)
Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. (2010) (150)
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. (2013) (147)
The pulmonary physician in critical care • Illustrative case 7: Assessment and management of massive haemoptysis (2003) (141)
A study of the prevalence of systemic sclerosis in northeast England. (2004) (132)
Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation (2009) (131)
Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. (1991) (129)
A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation (2012) (127)
IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts (2013) (127)
Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients (2005) (126)
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension (2017) (123)
Extended donor criteria in lung transplantation: impact on organ allocation. (2006) (123)
Outcomes of lung transplantation for cystic fibrosis in a large UK cohort (2008) (121)
Comparison of Mycophenolate Mofetil and Azathioprine for Prevention of Bronchiolitis Obliterans Syndrome in De Novo Lung Transplant Recipients (2006) (121)
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension (2013) (121)
Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury (1999) (116)
Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension (2019) (115)
Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. (1987) (115)
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. (2005) (109)
The Safety and Efficacy of Total Lymphoid Irradiation in Progressive Bronchiolitis Obliterans Syndrome After Lung Transplantation (2005) (109)
RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors (2017) (105)
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determi (2013) (101)
Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. (2013) (100)
Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts (2005) (99)
Safety of bronchial thermoplasty in patients with severe refractory asthma. (2013) (97)
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension (2019) (97)
Whole genome sequencing of a sporadic primary immunodeficiency cohort (2018) (92)
Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis. (1988) (92)
Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease. (2010) (91)
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia (2003) (91)
Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease (2010) (88)
Cross sectional study of exhaled nitric oxide levels following lung transplantation (1998) (88)
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study. (1993) (86)
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension (2017) (84)
Aetiology of asthma: lessons from lung transplantation (1993) (84)
Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. (2003) (83)
The effect of ex vivo lung perfusion on microbial load in human donor lungs. (2014) (82)
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland (2008) (82)
Fluid dynamics during bronchoalveolar lavage. (1988) (82)
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. (2004) (81)
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis (2019) (81)
Lung transplantation for lymphangioleiomyomatosis: the European experience. (2009) (80)
Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. (2004) (78)
Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. (2008) (76)
Functional Status and Quality of Life in Patients Surviving 10 years After Lung Transplantation (2005) (74)
Upper gastrointestinal dysmotility in heart-lung transplant recipients. (1993) (73)
Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). (2001) (69)
Nifedipine in the prevention of asthma induced by exercise and histamine. (1983) (69)
Inflammation and Epithelial to Mesenchymal Transition in Lung Transplant Recipients: Role in Dysregulated Epithelial Wound Repair (2010) (66)
Nebulised salbutamol and angina. (1982) (64)
Variability of inspired oxygen concentration with nasal cannulas. (1992) (63)
The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). (2007) (63)
Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. (2009) (63)
Assessing the burden of respiratory disease in the UK. (2002) (62)
Dose-response study of inhaled salbutamol powder in chronic airflow obstruction. (1983) (62)
Communicating the diagnosis of lung cancer. (1993) (61)
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension (2017) (60)
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension (2019) (59)
Primary airway epithelial cell culture from lung transplant recipients (2005) (57)
Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation. (2015) (56)
Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. (1994) (56)
Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. (2017) (56)
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. (2020) (55)
Nutritional state of patients with lung cancer undergoing thoracotomy. (1990) (53)
Amiodarone pulmonary toxicity: clinical and subclinical features. (1986) (52)
Lung transplantation, gastroesophageal reflux, and fundoplication. (2010) (52)
Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. (1997) (52)
Ciliary beat frequency in transplanted lungs. (1993) (52)
Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. (2001) (51)
Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor. (2001) (51)
Atrial septostomy for pulmonary arterial hypertension (2003) (50)
MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients. (1994) (50)
Lung transplantation outcome in cystic fibrosis patients with previous pneumothorax. (2005) (49)
Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation (2014) (48)
Recurrence of Langerhans’ cell granulomatosis following lung transplantation (1998) (48)
Objective assessment of criteria for selection of donor lungs suitable for transplantation (2004) (47)
A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea (2000) (46)
Pseudomonas aeruginosa accentuates epithelial-to-mesenchymal transition in the airway (2010) (45)
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation (2004) (45)
Improving donor lung evaluation: a new approach to increase organ supply for lung transplantation (1998) (45)
Healing of the bronchus in pulmonary transplantation. (1996) (45)
Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life (2011) (44)
Donor-acquired small cell lung cancer following pulmonary transplantation. (2001) (44)
The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer. (1988) (44)
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes (2018) (43)
Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis (2011) (43)
Appetite suppressants and primary pulmonary hypertension in the United Kingdom. (1995) (43)
Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion (2016) (43)
The immunohistopathology of obliterative bronchiolitis following lung transplantation. (1992) (43)
Exhaled single-breath nitric oxide measurements are reproducible, repeatable and reflect levels of nitric oxide found in the lower airways. (1998) (42)
Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. (1995) (42)
Targeting Allograft Injury and Inflammation in the Management of Post‐Lung Transplant Bronchiolitis Obliterans Syndrome (2009) (42)
Pulmonary arterial hypertension and lung transplantation (2011) (41)
Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients (2003) (40)
Breast lumps: rare presentation of oat cell carcinoma of lung. (1988) (40)
ORGANIZING PNEUMONIA FOLLOWING PULMONARY TRANSPLANTATION AND THE DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS1 (1994) (40)
Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. (1995) (39)
Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction (2016) (39)
Airway complications after pulmonary transplantation. (1994) (38)
Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension (2018) (38)
An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe (2017) (38)
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. (2021) (38)
Mediastinitis in heart and lung transplantation: 15 years experience. (2003) (38)
Perfadex for clinical lung procurement: is it an advance? (2003) (37)
Assessment of phagocytic function using chemiluminescence. (1989) (37)
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome (2008) (36)
Pulmonary transplantation for cystic fibrosis: pre-transplant recipient characteristics in patients dying of peri-operative sepsis. (2003) (34)
TNFα From Classically Activated Macrophages Accentuates Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis (2013) (34)
Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. (2008) (33)
Alemtuzumab (Campath-1H) for treatment of refractory polymyositis. (2008) (33)
Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia (1994) (32)
Lung transplantation and the Burkholderia cepacia complex. (2003) (32)
Bile acid aspiration in people with cystic fibrosis before and after lung transplantation (2015) (31)
NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice (2018) (31)
A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation (2005) (30)
Comparison of the functional results of single lung transplantation for pulmonary fibrosis and chronic airway obstruction. (1998) (29)
Reimplantation injury after lung transplantation in a rat model. (1987) (29)
Successful surgical management of bronchial dehiscence after single-lung transplantation. (1990) (28)
The structure and proinflammatory activity of the lipopolysaccharide from Burkholderia multivorans and the differences between clonal strains colonizing pre and posttransplanted lungs. (2008) (28)
Primary bronchial epithelial cell culture from explanted cystic fibrosis lungs (2010) (28)
Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. (1993) (28)
Update in transplantation 2007. (2008) (27)
Bilateral sequential lung transplantation for end stage septic lung disease. (1995) (27)
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome (2020) (27)
Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls. (1999) (27)
Single lung transplantation with simultaneous contralateral pneumonectomy for cystic fibrosis. (1994) (27)
One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation. (2001) (26)
Adverse effect of additional weight on exercise against gravity in patients with chronic obstructive airways disease. (1989) (26)
Lung transplants in patients with prior bone marrow transplants. (1994) (26)
Lung Transplantation for Cystic Fibrosis and Bronchiectasis (2013) (26)
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures (2018) (26)
Enhanced avidity from a multivalent fluorescent antimicrobial peptide enables pathogen detection in a human lung model (2019) (26)
Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation (2018) (26)
The current state of lung transplantation. (1989) (25)
Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts (2007) (25)
Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells (2008) (25)
Generalised lymphangiectasia: pulmonary presentation in an adult. (1996) (25)
Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation (2006) (24)
Bile acids are present in the lower airways of people with cystic fibrosis. (2012) (24)
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. (2007) (24)
Donor-acquired fat embolism causing primary organ failure after lung transplantation. (1995) (24)
Ciprofloxacin: a preferred treatment for legionella infections in patients receiving cyclosporin A. (1988) (24)
Nifedipine enhances the bronchodilator effect of salbutamol. (1984) (24)
IL-1a released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts (2014) (24)
Early results of single lung transplantation in patients with end-stage pulmonary fibrosis. (1989) (24)
Impaired gastrointestinal motility in pulmonary transplantation (1990) (23)
Pregnancy after lung and heart-lung transplantation. (2014) (23)
279: The Effect of Ex-Vivo Perfusion on the Microbiological Profile of the Donor Lung (2010) (23)
Distribution of gamma delta T-cells in the bronchial tree of smokers and non-smokers. (1993) (23)
Are the enzymatic methods currently being used to measure bronchoalveolar lavage bile salt levels fit for purpose? (2013) (22)
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis (2019) (22)
The biphasic spirogram: a clue to unilateral narrowing of a mainstem bronchus. (1990) (22)
Significance of Epstein–Barr virus status and post‐transplant lymphoproliferative disease in pediatric thoracic transplantation (1999) (22)
Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation. (2000) (22)
Palliation of systemic sclerosis-associated pulmonary hypertension by atrial septostomy. (2001) (22)
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension. (2005) (22)
The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension (2017) (22)
A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. (2005) (21)
Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation (2007) (21)
Native pulmonary sepsis after single-lung transplantation. (1991) (21)
Platypnoea-orthodeoxia in cryptogenic fibrosing alveolitis. (1995) (20)
Prediction of chronic lung allograft dysfunction: a systems medicine challenge (2014) (20)
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation (2014) (20)
Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus. (1984) (19)
Hypothesis: epithelial-to-mesenchymal transition is a common cause of chronic allograft failure. (2005) (18)
Single-flush perfusion with modified Euro-Collins solution: experience in clinical lung preservation. (1992) (18)
Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema (2013) (17)
Cushing's syndrome without excess cortisol (2006) (17)
The effect of controlled-release salbutamol on sleep and nocturnal oxygenation in patients with asthma and chronic obstructive pulmonary disease. (1994) (17)
First structural characterization of Burkholderia vietnamiensis lipooligosaccharide from cystic fibrosis-associated lung transplantation strains. (2009) (16)
Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors. (2017) (16)
Effect of granulocyte‐macrophage colony‐stimulating factor on neutrophil function in idiopathic bronchiectasis (2013) (16)
Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing (2012) (16)
Outcomes of lung transplantation in adults with bronchiectasis (2018) (15)
Cardiovascular and respiratory effects of adenosine in humans after pulmonary denervation. (1994) (15)
Airway Epithelial Cell Senescence in the Lung Allograft (2008) (15)
Bilateral lung transplant: the procedure of choice for end-stage septic lung disease. (2001) (14)
Long-term effect of azithromycin in bronchiolitis obliterans syndrome (2019) (14)
Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease. (1991) (14)
The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patients. (2006) (14)
The interface between primary and secondary care. (2001) (14)
Update in transplantation 2006. (2007) (14)
Respiratory mechanics after heart-lung and bilateral lung transplantation. (1997) (14)
Call it by the correct name - pulmonary hypertension not pulmonary arterial hypertension. (2020) (13)
Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). (2002) (13)
Mycophenolate Mofetil (MMF) vs Azathioprine (AZA) in lung transplantation for the prevention of Bronchiolitis Obliterans Syndrome (BOS): results of a 3 year international randomised trial (2003) (13)
Atrial septostomy and transplantation for patients with pulmonary arterial hypertension. (2009) (13)
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension (2021) (13)
Observational study of lung transplant recipients surviving 20 years. (2016) (12)
Differential pulmonary vein gases predict primary graft dysfunction. (2006) (12)
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood (2021) (12)
Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation (2009) (12)
Lung transplantation from deceased donors without pretreatment (2007) (12)
Lung transplantation for chronic obstructive pulmonary disease: an exercise in quality rather than quantity? (1999) (12)
Alternatives to lung transplantation: treatment of pulmonary arterial hypertension. (2011) (12)
Sirolimus for lymphangioleiomyomatosis lesions. (2008) (12)
Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids (2004) (12)
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? (2020) (12)
323 Successful Transplantation of Unusable Donor Lungs Using Ex-Vivo Lung Perfusion: The Newcastle Experience (2012) (11)
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection (2016) (11)
Effects of diffuse pleural thickening on respiratory mechanics. (1988) (11)
Lung transplantation for cystic fibrosis (2008) (11)
Bronchial termoplasty improves asthma status of moderate-to-servere-persistent asthmatics over and above current standard-of-care (2006) (11)
Detection of occult cardiac invasion by two dimensional echocardiography in patients with bronchial carcinoma. (1986) (11)
A call for standardization of antireflux surgery in the lung transplantation population. (2009) (11)
323 Successful Transplantation of Unusable Donor Lungs Using Ex-Vivo Lung Perfusion: The Newcastle Experience (2012) (11)
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment (2004) (10)
Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation (2009) (10)
Bronchiolitis obliterans syndrome (2003) (10)
Sleep apnoea/hypopnoea syndrome: a potential cause of graft failure following heart transplantation. (1998) (10)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications (2017) (10)
Lung transplantation. Bronchiolitis obliterans syndrome. (2003) (9)
NON-HEART BEATING LUNG DONATION: ASPECTS FOR THE FUTURE (2002) (9)
Carbamazepine-induced interstitial pneumonitis in a lung transplant patient. (2006) (9)
Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study (2018) (9)
Azathioprine-related interstitial pneumonitis in a renal transplant recipient. (1992) (9)
Mononuclear phagocyte populations in the transplanted human lung. (1998) (9)
Lung transplantation for cystic fibrosis; the effect of B cepacia genomovars on post transplant outcomes. (2001) (8)
Structural Elucidation of a Novel B. cenocepacia ET-12 Lipooligosaccharide Isolated from a Cystic Fibrosis Patient after Lung Transplantation (2010) (8)
Iatrogenic pulmonary artery pseudoaneurysm: images from different modalities (2008) (8)
Asthma presenting as cor pulmonale. (1984) (8)
Isolated lung transplantation for pulmonary fibrosis (1990) (8)
Neurofibrosarcoma of the vagus nerve (1983) (8)
Respiratory health and disease in a UK population-based cohort of 85 year olds: The Newcastle 85+ Study (2016) (7)
Structural modifications of the antimicrobial peptide ubiquicidin for pulmonary imaging of bacteria in the alveolar space (2016) (7)
Intragraft proliferating T lymphocytes are associated with moderate acute pulmonary rejection. (2000) (7)
A prospective randomized comparison of fine needle aspiration biopsy and fibreoptic bronchoscopy in the investigation of peripheral pulmonary opacities. (1989) (7)
Methotrexate pneumonitis in a patient with rheumatoid arthritis. (1997) (6)
Effects of drug abuse, smoking and alcohol on donor hearts and lungs (2019) (6)
Surgical management of infective endocarditis after heart-lung transplantation. (1993) (6)
Identification of those at risk after acute pulmonary embolism (2009) (6)
Opportunist pulmonary infection with Legionella bozemanii. (1989) (6)
Interleukin-17 and cystic fibrosis lung disease. (2012) (6)
Cryptogenic organizing pneumonia is an important cause of graft dysfunction and should be included in the classification of pulmonary allograft rejection. (1998) (6)
Observational Study of Methotrexate in the Treatment of Bronchiolitis Obliterans Syndrome. (2016) (6)
Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH (2020) (6)
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension (2020) (6)
Invasive biopsy is effective and useful after lung transplant. (2009) (6)
Alveolar macrophage function before and during treatment with cytotoxic chemotherapy in patients with small cell lung cancer. (1991) (5)
FLUCONAZOLE AND CANDIDOSIS (1989) (5)
Lung transplantation and asthma (1993) (5)
5-year Safety of Bronchial Thermoplasty Demonstrated in Patients with Moderate to Severe Asthma: Asthma Intervention Research (AIR) Trial (2010) (5)
Application of the REVEAL risk score calculator 2.0 in the PATENT study. (2021) (5)
Identical Biofilm Forming Strains of Pseudomonas aeruginosa Occur in Lung Allograft BAL and Gastric Juice from CF Patients with Gastro Oesophageal Reflux (2013) (5)
Prophylaxis post-transplant. The role of monitoring surveillance bronchoscopy and antimicrobials. (1997) (5)
Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension? (2015) (5)
Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis. (2014) (5)
The RESPITE Study: Riociguat In Patients With Pah And An Inadequate Response To Phosphodiesterase 5 Inhibitors (2016) (5)
The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation. (1993) (5)
Late Breaking Abstract - Switching from PDE5i to riociguat in patients with PAH: The REPLACE study (2020) (5)
351: Refining the identification of discriminatory genes for rejection in lung transplantation: The LARGO Study (2007) (5)
A European Multi-Center, Randomized, Double-Blind Trial of Pirfenidone in Bronchiolitis-Obliterans-Syndrome Grade 1-3 in Lung Transplant Recipients (European Trial of Pirfenidone in BOS (EPOS)). (2020) (4)
Effects of diazepam and chlormethiazole on ventilatory control in normal subjects. (1984) (4)
The UK National Pulmonary Hypertension Service, Registry and Research Collaboration (2015) (4)
The value of flow cytometric crossmatch in cardiac transplantation (1994) (4)
Interpleural Analgesia Improves Pulmonary Function After Cholecystectomy Symptomatic Benefit of Supplemental Oxygen in Hypoxemic Patients with Chronic Lung Disease (1991) (4)
OPPORTUNISTIC PNEUMONIA CAUSED BY LEGIONELLA BOZEMANII (1988) (4)
Epithelial to mesenchymal transition in clinically stable lung transplant recipients (2005) (4)
Breaking Down the Barriers: Why the Delay in Referral for Pulmonary Arterial Hypertension? (2016) (4)
Rationale and Study Design of the RESPITE Trial: Riociguat Clinical Effects Studied in Pulmonary Arterial Hypertension (PAH) Patients With Insufficient Treatment Response to PDE-5 Inhibitors (PDE-5i) (2015) (4)
A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. (2018) (4)
Living lobar lung transplantation (2002) (4)
Functional and Quality of Life Improvements in Treated Patients with Chronic Thromboembolic Pulmonary Hypertension (2013) (4)
Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung Transplantation. (2014) (4)
REPLACE: A prospective, randomized trial of riociguat replacing phosphodiesterase 5 inhibitor therapy in patients with pulmonary arterial hypertension who are not at treatment goal (2017) (4)
Bronchus associated lymphoid tissue in human lung : its distribution in smokers and non-smokers Figure 1 Low power photomicrograph of bronchial wall elements with a deeply situated focus of BALT (2004) (4)
RESPITE: Riociguat in pulmonary arterial hypertension patients with an inadequate response to phosphodiesterase type 5 inhibitors (2016) (4)
Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension. 2 Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort. 2 Initial combination therapy (2016) (4)
Medical training in the UK: sleepwalking to disaster (2007) (4)
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. (2022) (3)
Cutaneous tuberculosis in an immunocompromised host: an unusual clinical presentation (1995) (3)
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study (2020) (3)
(231) - NonTuberculous Mycobacteria Infection and Lung Transplantation in Cystic Fibrosis: A Worldwide Survey of Clinical Practice (2017) (3)
111: Colonization of lung transplant recipients with Pseudomonas Aeruginosa and the development of bronchiolitis obliterans syndrome (2006) (3)
Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience (2016) (3)
A Multicentre Study of Anticoagulation in Operable Chronic Thromboembolic Pulmonary Hypertension (2019) (3)
Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry (2016) (3)
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension (2020) (3)
MHC CLASS II AND ICAM‐1 EXPRESSION AND LYMPHOCYTE SUBSETS IN TRANSBRONCHIAL BIOPSIES FROM LUNG TRANSPLANT RECIPIENTS1 (1994) (3)
Post heart/lung transplantation management. (1995) (3)
Alveolar macrophage and blood monocyte function in lung cancer. (1991) (3)
Pulmonary transplantation for CF: The effect of B. cepacia genomovars on outcomes (2000) (3)
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan (2013) (3)
Bilateral sequential lung transplantation for septic lung disease: surgical and physiologic advantages over heart-lung transplantation. (1992) (3)
The Role of Genomovars in Burkholderia Cepacia Proinflammatory Activity (2000) (3)
Lung transplantation. (2007) (3)
Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study (2021) (3)
Longitudinal changes in gastro-oesophageal reflux from three months to six months post lung transplantation (2010) (3)
The Achilles heel of endothelin receptor therapy for pulmonary arterial hypertension (2010) (3)
Single flush perfusion with Euro-Collins solution in lung preservation: clinical assessment of early graft function. (1990) (3)
Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. (2020) (3)
Respiratory medicine: fighting for survival. (1992) (3)
Spinal Cord Compression in Polyarteritis Nodosa (1992) (3)
Ventilation perfusion radionuclide imaging in cryptogenic fibrosing alveolitis (1993) (3)
S65 Large and small airway epithelial cell senescence present in COPD and bronchiectasis? (2013) (2)
Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart Function (2018) (2)
Risk stratification in PAH (2020) (2)
Ceramide is increased and associated with neutrophilic inflammation in the lower airway epithelium of people with cystic fibrosis (2009) (2)
178: Does Pepsin in Gastric Juice Aspirated into the Lung Allograft Stimulate Mucus Hypersecretion? (2008) (2)
Induction Therapy in Lung Transplantation? A Frustrating Message of Persisting Uncertainty (2016) (2)
642: Effectiveness of Targeted Pro-Active Management of Aspergillus fumigatus Infections before and after Lung Transplantation (2009) (2)
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension (2021) (2)
100: Immunoregulatory influences on peripheral blood gene expression in lung transplant patients: The lung allograft rejection gene expression observational (Largo) study (2006) (2)
ProÞling inßammation and tissue injury markers in perfusate and bronchoalveolar lavage ßuid during human ex vivo lung perfusion (2019) (2)
Pulmonary artery to coronary artery fistula after transbronchial lung biopsy (1993) (2)
Blood neutrophil and monocyte function following chemotherapy in patients with small cell lung cancer (1991) (2)
Bronchial Thermoplasty in Refractory Asthma: Interim Results in a Severe Asthma Population (Research in Severe Asthma (RISA) Trial) (2007) (2)
Responder Analysis of AQLQ in the Asthma Intervention Research (AIR) Trial (2009) (2)
An immunohistochemical method for the detection of tumour necrosis factor alpha in cytospins of human bronchoalveolar lavage cells (1995) (2)
Survival in pulmonary hypertension registries: the importance of incident cases. (2011) (2)
524: Serial NT-probrain natriuretic peptide (NT-proBNP) levels in patients with pulmonary arterial hypertension (PAH) (2007) (2)
Lung transplantation in patients with cystic fibrosis. (1996) (2)
Methotrexate as a Treatment Strategy for Bronchiolitis Obliterans Syndrome (BOS) (2015) (2)
Outcomes of lung transplantation for bronchiectasis (2012) (2)
Asthma Intervention Research (AIR) Trial Evaluating Bronchial Thermoplasty: Early Results (2006) (2)
A practical approach to the diagnosis of venothromboembolism. (2001) (2)
504: The Effect of Ex-Vivo Perfusion on the Inflammatory Profile of the Donor Lung (2010) (2)
Lung transplantation for cystic fibrosis (CF); the effect of Burkholderia cepacia genomovars on outcomes (2001) (2)
S71 Influence of age on clinical phenotypes of incident idiopathic pulmonary arterial hypertension. Results from the pulmonary hypertension registry of the UK and Ireland (2011) (2)
EPITHELIAL TO MESENCHYMAL TRANSITION IN CLINICALLY STABLE LUNG TRANSPLANTATION. (2004) (2)
The value of flow cytometric crossmatching in lung transplantation: relevance of pretransplant antibodies to lung epithelial cells. (1995) (2)
Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (2)
The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI) (2020) (1)
The prognostic significance of 3 tumour markers (NSE, TPA, SACE) in patients with small cell lung cancer (1991) (1)
P160 The Role Of Specialist Palliative Care Services In The Management Of Patients With Pulmonary Arterial Hypertension; A Review Of Current Practice (2014) (1)
nternational Guidelines for the Selection of Lung Transplant andidates : 2006 Update — A Consensus Report From the ulmonary Scientific Council of the International Society or Heart and Lung Transplantation (2006) (1)
Antimicrobial peptides and airway innate immunity in the pathophysiology of bronchiolitis obliterans syndrome (BOS) after lung transplantation (2006) (1)
S100 Novel T helper cell responses against Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis (2013) (1)
Functional status of 10 year survivors after lung transplantation (2003) (1)
Longitudinal assessment of pepsin levels in lung allografts suggests aspiration is an ongoing injury, which can occur early following lung transplantation (2008) (1)
Use of Preoperative Perfusion Scanning to Predict Exercise Performance after Pneumonectomy for Carcinoma of the Bronchus (1983) (1)
Patient selection for lung transplantation. (1998) (1)
Anaemia in lung transplant recipients. effect on health related quality of life (2004) (1)
Reticular basement membrane thickening in end-stage cystic fibrosis lung disease (2009) (1)
BAL neutrophil levels in a randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome post lung transplantation (2012) (1)
Novel causative genes for heritable pulmonary arterial hypertension (2017) (1)
320: The phosphodiesterase type IV (PDE IV) inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells derived from lung transplant recipients (2006) (1)
Co-localisation of MMP-9 (gelatinase B) with airway neutrophils in stable lung transplant recipients-A potential role in the bronchiolitis obliterans syndrome (2003) (1)
Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland (2011) (1)
The importance of deep phenotyping PH registries with a focus on the PVRI-GoDeep registry (2020) (1)
Measurement of respiratory nitric oxide in patients undergoing cardiopulmonary bypass (2001) (1)
Culture of Mycobacterium kansasii in the blood of an HIV negative patient. (1993) (1)
Amiodarone pulmonary toxicity (1984) (1)
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (1)
An immunohistochemical method for the detection of tumour necrosis factor alpha in cytospins of human bronchoalveolar lavage cells (2004) (1)
Comparison of total lymphoid irradiation (TLI) versus tacrolimus for the treatment of obliterative bronchiolitis (OB) in lung transplants. (2001) (1)
Donor selection and management (2003) (1)
Single centre prognostic modelling of cystic fibrosis patients referred for lung transplantation (2004) (1)
Genetic polymorphisms and bronchiolitis obliterans syndrome post lung transplantation (2005) (1)
Randomised trial of oral verapamil with chemotherapy for non-small cell lung cancer (NSCLC) (1991) (1)
The good the bad and the ugly (2014) (1)
Recent advances in the treatment of small cell lung cancer. (1989) (1)
Outcomes in embolisations of pulmonary arterio-venous malformations (2014) (1)
Safety of bronchial thermplasty in patients with severe refractory asthma. (2013) (1)
S146 Microvascular endothelial cell apoptosis and dysregulation of Vascular Endothelial Growth Factor Receptor 2 (VEGF-R2) in response to cigarette smoke. New insights into the pathogenesis of emphysema (2010) (1)
A pilot study of digital feedback to guide therapeutic decisions in pulmonary hypertension (2016) (1)
Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study. (2020) (1)
The Relationship Between NO Pathway Biomarkers and Response to Riociguat in the RESPITE Study of Patients With PAH Not Reaching Treatment Goals With Phosphodiesterase 5 Inhibitors (2016) (1)
112: Does the BODE Index Predict Survival in Patients with COPD Referred for Lung Transplantation? (2009) (1)
Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study (2017) (1)
Acute pulmonary embolism: clinical aspects. (1998) (1)
S72 Prediction of survival in pulmonary arterial hypertension using survival equations. Results from the pulmonary hypertension registry of the UK and Ireland (2011) (1)
Treating Donor Lung Inflammation by Blocking Interleukin-1Β - An In Vitro Therapy Testing Platform for Ex Vivo Lung Perfusion (2016) (1)
S21 Identification of Pseudomonas aeruginosa infection via volatile organic compounds in sputum headspace gases (2010) (1)
SWITCHING TO RIOCIGUAT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION NOT AT TREATMENT GOAL WITH PHOSPHODIESTERASE TYPE-5 INHIBITORS: SUBGROUP ANALYSIS RESULTS OF THE REPLACE STUDY (2020) (1)
196: Variability in the Pathologic Interpretation of Trans-Bronchial Lung Biopsy after Lung Transplantation. Clinical Implications (2008) (1)
Identification of novel rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (1)
Assessment of the REPLACE Study Composite Endpoint in the PATENT Study and Association with Long-Term Outcomes in Riociguat-Treated Patients (2019) (1)
Treatment Outcomes in Pulmonary Arterial Hypertension (PHA) Associated with Systemic Sclerosis (Sscl.) in Matched Groups Using Either Bosentan or Sildenafil Monotherapy (2013) (1)
285* The impact of BMI on survival of patients with cystic fibrosis undergoing lung transplantation: a single centre experience (2011) (1)
Evidence of increased gastric aspiration in acute lung allograft rejection (2006) (1)
The effect of inhaled steroids on exhaled nitric oxide (eNO) in lung transplant recipients with lymphocytic bronchitis (1999) (1)
The culture of primary bronchial epithelial cells from the lungs of people with cystic fibrosis removed at the time of transplantation: a model to study cystic fibrosis lung disease (2008) (1)
REDUCTION IN MILD EXACERBATION RATES AND IMPROVEMENT IN ASTHMA STATUS FOLLOWING BRONCHIAL THERMOPLASTY (2006) (1)
Quality of life and predictions of survival in patients with advanced emphysema. (1995) (1)
S40 Phenotypic characterisation of GDF2 mutation carriers in a large cohort of patients with pulmonary arterial hypertension (2018) (1)
Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial (2011) (1)
The pulmonary innate immune response to pseudomonas aeruginosa infection in human lung transplant recipients (2005) (0)
AUTHOR'S REPLY (1990) (0)
Longitudinal Analysis of Three Major Risk-Associated Transcriptomic Subgroups Within the IPAH Classification (2022) (0)
Guidelines on the identification and treatment of pulmonary hypertension. (2009) (0)
Pro-inflammatory cytokines dysregulate lung epithelial wound repair via epithelial to mesenchymal transition (2008) (0)
S108 Genome-wide association study in chronic thromboembolic pulmonary hypertension reveals new insights into aetiology (2017) (0)
135 Evolving Experience with Donor Lung Bronchoalveolar Lavage (2011) (0)
Oxidative stress induces epithelial to mesenchymal transition in bronchial epithelial cells: A possible role in airway remodelling (2006) (0)
haemoptysis7: Assessment and management of massive The pulmonary physician in critical careIllustrative (2007) (0)
Sensitivity and specificity of exhaled nitric oxide in identifying graft inflammation in lung transplant recipients. (1999) (0)
FOR THE FUTURE NON-HEART BEATING LUNG DONATION: ASPECTS (2007) (0)
278: Pro-Inflammatory Cytokines IL-1β and TNFα, but Not IL-8, Cause Aberrant Lung Epithelial Wound Repair Via TGF-β1 Driven Epithelial to Mesenchymal Transition (EMT) (2009) (0)
Genetic determinants of risk and survival in pulmonary arterial hypertension (2018) (0)
Tumour necrosis factor-alpha accentuates transforming growth factor-beta driven epithelial to mesenchymal transition in lung epithelial cells (2006) (0)
Use of the Multi Combination Bactericidal Test to detect optimal antimicrobial combinations for the treatment of Pseudomonas aeruginosa and Burkholderia cepacia in patients undergoing lung transplantation (2005) (0)
68: Stress-induced premature senescence in airway epithelium and accelerated lung allograft aging (2007) (0)
The Effect of Ex-Vivo Perfusion on the Inflammatory Cytokine Profile of the Donor Lung (2010) (0)
Faculty Opinions recommendation of Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. (2011) (0)
Should we be giving high concentration oxygen to all patients treated in an ambulance? (2012) (0)
Cushingaposs syndrome without the cortisol (2005) (0)
Alternatives to Lung Transplantation: of Pulmonary Arterial Hypertension (2011) (0)
ThoraxAbstract 53..53 (2013) (0)
BRAINSTEM DEATH NEUTROPHIL CHEMOTACTIC ACTIVITY IN THE DONOR LUNG BY INCREASED INTRA-ALVEOLAR C-X-C CHEMOKINE EXPRESSION. (1999) (0)
Nifedipine enhances the bronchodilator effect of salbutamol AML (0)
S107 Genotype-phenotype associations in pulmonary arterial hypertension caused by BMPR2 and EIF2AK4 variants (2016) (0)
Randomised Controlled Trial Of Granulocyte Macrophage Colony Stimulating Factor In Critically Ill Patients With Impaired Neutrophil Function (2016) (0)
Association between the genotype of the TNF locus and acute rejection following lung transplant (2005) (0)
Prevalence of pulmonary hypertension in limited cutaneous systemic sclerosis (1999) (0)
Human Pulmonary Microvascular Endothelial Cells Undergo Apoptosis And Down Regulate Vascular Endothelial Growth Factor Receptor 2 (VEGF-R2) In Response To Cigarette Smoke Extract (2011) (0)
Abstract 14413: Whole Genome Sequencing in Idiopathic and Familial Pulmonary Arterial Hypertension Reveals Causal Rare Coding and Non-coding Sequence Variation (2016) (0)
Airway Inflammation and Exhaled Nitric Oxide in Pulmonary Transplantation (1998) (0)
S53 Alarmins in bronchiolitis obliterans syndrome after lung transplantation (2011) (0)
WS17.6 Cystic fibrosis airway epithelial cells interact with dendritic cells to produce immune tolerance (2012) (0)
Neurofibrosarcoma ofthevagus nerve (1983) (0)
P138 Baseline Hypoxemia Predicts Survival in Patients with Idiopathic Pulmonary Arterial Hypertension Without Patent Foramen Ovale (2012) (0)
553 The Epithelial Alarmin, Interleukin 1 α (IL-1α), Is a Potential Fibrogenic Factor in Bronchiolitis Obliterans Syndrome (BOS) (2011) (0)
Oxidative stress induces epithelial to mesenchymal transition in human lung epithelial cells through transforming groeth factor beta and integrin beta6-dependent mechanism (2008) (0)
Post-transplant changes in exhaled nitric oxide (eNO) of pulmonary transplant recipients and the influence of mycophenolate (MMF) (2002) (0)
Angiotensin converting enzyme inhibitor cough: Lessons from heart–lung transplantation (1998) (0)
Long term administration of intravenous (IV) Iloprost for pulmonary arterial hypertension (2006) (0)
Co-Localisation of Mmp-9 (Gelatinase B) with Airway Neutrophils in Stable Lung Transplant Recipients — a Potential Role in Bronchiolitis Obliterans Syndrome (2003) (0)
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications (2017) (0)
Changing features of patients with cystic fibrosis (CF) referred for lung transplantation assessment (2008) (0)
Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study. (2020) (0)
Co-localisation of MMP-9 with neutrophils in stable lung transplant recipients - A potential role in Bronchiolitis Obliterans (2002) (0)
277* Outcome following lung transplantation for patients with cystic fibrosis related liver disease: a single centre experience (2011) (0)
Success of sputum induction as a method of monitoring inflammatory events following lung transplantation (2001) (0)
Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in incident idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland (2011) (0)
Improving Outcomes in Lung Transplantation for Cystic Fibrosis – A Unified Approach (2013) (0)
Faculty Opinions recommendation of Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. (2008) (0)
Present Status and Assessment of Lung Transplantation (1993) (0)
Oxidative stress increases transforming growth factor-beta expression and drives epithelial to mesenchymal transition in human lung epithelial cells (2007) (0)
Successful transplantation of B. cepacia complex infected cystic fibrosis patients; transplanting B. cenocepacia (genomovar III) infected patients (2004) (0)
Negative association between CMV-viraemia and Bronchiolitis Obliterans Syndrome in lung transplant recipients (2005) (0)
520: Bronchalveolar Lavage Neutrophilia and MMP-9 at 3 Months Post Lung Transplantation May Predict the Development of BOS (2009) (0)
459: Azithromycin Attenuates Lipopolysaccharide-Mediated Release of Interleukin-8 and GM-CSF from Primary Bronchial Epithelial Cells Derived from Stable Lung Transplant Recipients (2008) (0)
Lung Transplantation: Medical management (2003) (0)
IL-17 stimulates IL-8 release in primary epithelial cell cultures derived from lung allografts (2004) (0)
donor lungs suitable for transplantation Objective assessment of criteria for selection of (2007) (0)
103 Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas Aeruginosa (2011) (0)
50: Lung Function after Single Lung Transplantation (SLTx): Emphysema Versus Pulmonary Fibrosis (2008) (0)
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension (2018) (0)
nterventional and Surgical Modalities of reatment for Pulmonary Arterial Hypertension (2004) (0)
Transforming growth factor beta 1 suppresses secretory leucoprotease inhibitor release in response to infection in lung epithelial cells (2008) (0)
P173 Prognostic factors for survival in idiopathic pulmonary arterial hypertension (2017) (0)
Survival Of Incident Cases Of Idiopathic, Heritable And Anorexigen-Associated Pulmonary Arterial Hypertension. Results From Pulmonary Hypertension Registry Of The United Kingdom And Ireland (Proud Registry) (2011) (0)
Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
Commentary (1995) (0)
Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients. (2020) (0)
Detection ofoccult cardiac invasion bytwo dimensional echocardiography inpatients with bronchial carcinoma (1986) (0)
The Relationship of Hemodynamics and Exercise Capacity With Response to Riociguat Therapy in the Respite Study of PAH Patients With an Insufficient Response to Phosphodiesterase 5 Inhibitors (2017) (0)
Genome Wide Association Studies In Chronic Thromboembolic Pulmonary Hypertension (2016) (0)
stage fibrosing lung disease . pulmonary hypertension in patients with end Effect of single lung transplantation on (2004) (0)
Useofradionuclide scanning inthepreoperative estimation ofpulmonary function after (1987) (0)
as a trigger for referral for lung transplantation Pulmonary fibrosis: rate of disease progression (2007) (0)
Cyst-leukotriene (cys-LT1) receptors in nasal polyps (2001) (0)
The Presence of Quorum Sensing Signal Molecules in Clinically Stable Lung Allograft Recipients Suggests Bacterial Biofilm Biology (2003) (0)
Multi-omic profiling in pulmonary arterial hypertension (2020) (0)
The prognostic value of monocyte function in patients with small cell lung cancer (SCLC) (1991) (0)
The Epithelial Alarmin, Interleukin 1 alpha (IL-1 alpha), Is a Potential Fibrogenic Factor in Bronchiolitis Obliterans Syndrome (BOS) (2011) (0)
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
Successful outcome following lung transplantion for recipients colonised with filamentous fungi at time of transplant (2005) (0)
Aspiration Secondary to Gastro-Oesophageal Reflux but not Duodenal Reflux Occurs in the Immediate Post Lung Transplantation Period (2009) (0)
The effect of ex vivo lung perfusion on proinflammatory and anti-inflammatory cytokines in the human lung (2009) (0)
Remembering Robyn Barst. (2013) (0)
27: Tumour Necrosis Factor-α Accentuates Transforming Growth Factor-β Driven Epithelial to Mesenchymal Transition (EMT) in Airway Epithelial Cells from Lung Transplant Recipients (2008) (0)
Bronchial Thermoplasty Benefits Patients Following Withdrawal of LABA Therapy (2010) (0)
Respiratory health at the extremes of the ageing population: Initial results of the UK Newcastle 85+ study (2012) (0)
Whole Genome Sequencing In Idiopathic And Heritable Pulmonary Arterial Hypertension (2016) (0)
Clinically silent gastric aspiration is common in lung allografts (2004) (0)
Epithelial mesencymal transition occurs in primary airway epithelial cells in response to transforming growth factor-beta and epidermal growth factor (2006) (0)
Alveolar septae in severe end-stage emphysema show morphological evidence of dysregulated mesenchymal cell proliferation and loss of microvascularity (2007) (0)
Microvascular Endothelial Function in treated Pulmonary Arterial Hypertension (2017) (0)
Prognostic Significance Of Change In Functional Class In Incident Idiopathic Pulmonary Arterial Hypertension. Results From The Pulmonary Hypertension Registry Of The United Kingdom And Ireland (2012) (0)
Nutritional state ofpatients with lung cancer undergoing thoracotomy Preoperative nutritional indices of the patients who developed bronchopleuralfistula Patient BMI Skinfold Albumin * Transferrin (0)
Abstract 14753: Loss of Function ABCC8 Mutations Are Associated With Pulmonary Arterial Hypertension (2017) (0)
Asthma severity and improvements in asthma status following bronchial thermoplasty (BT). (2008) (0)
Pulmonary Disease in Association with Primary Biliary Cirrhosis (1983) (0)
bronchial tree of smokers and non-smokers . Distribution of gamma delta T-cells in the (0)
Difficult issues in the selection of cystic fibrosis patients for lung transplantation (2006) (0)
Faculty Opinions recommendation of Notch3 signaling promotes the development of pulmonary arterial hypertension. (2010) (0)
Premature senescence of airway epithelial cells: A possible role in airway remodelling after human lung transplantation (2006) (0)
P243 A Retrospective Observational Study Of 20 Year Lung Transplant Survivors – A Single Centre Experience (2014) (0)
EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study (2021) (0)
Investigating large and small airway epithelial cell senescence in COPD and bronchiectasis (2013) (0)
437 Misidentification of Burkholderia cenocepacia and the Implications for Lung Transplantation for Cystic Fibrosis (2011) (0)
Comparison Of Tunneled Central Venous Catheter Related Blood Stream Infections In Patients With Pulmonary Arterial Hypertension (PAH) Treated With IV Iloprost And IV Treprostinil (2010) (0)
231: Twenty Years Experience of Heart Lung Transplantation for Pulmonary Vascular Disease (2009) (0)
Should Patients With Emphysema Be Offered Lung Transplantation (2004) (0)
Sildenafil citrate therapy for pulmonary arterial hypertension (vol 353, pg 2148, 2005) (2006) (0)
Medical Treatment Of Chronic Thromboembolic Pulmonary Hypertension (2010) (0)
Pulmonary arterial hypertension and lung (2011) (0)
The nutritional status of patients with small cell lung cancer before and during treatment with chemotherapy (1991) (0)
for end stage septic lung disease . Bilateral sequential lung transplantation (0)
Whole-genome sequencing of patients with rare diseases in a national health system (2020) (0)
112: Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome – A Three Year Follow Up (2008) (0)
The impact of long-term air pollution and traffic on outcome after lung transplantation in Europe (2015) (0)
421: Simvastatin Potentially Decreases Neutrophilic Inflammation and Remodelling in the Transplanted Airway (2008) (0)
Hepatocyte growth factor - A link between neutrophilic inflammation and BOS? (2006) (0)
Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation (2012) (0)
S122 The M1 macrophage phenotype accentuates TGF-β1 driven epithelial to mesenchymal transition (EMT) via the secretion of TNFα (2010) (0)
Transplantation and Thromboendarterectomy for Severe Pulmonary Hypertension: Report from the Transplant and Interventions Task Force (2003) (0)
Mortality of idiopathic / hereditary and connective tissue disease-associated pulmonary arterial hypertension : the data from first single-center prospective registry in Indonesia (2021) (0)
Commentary (1996) (0)
Structural Elucidation of a Novel B. cenocepacia ET‐12 Lipooligosaccharide Isolated from a Cystic Fibrosis Patient After Lung Transplantation. (2010) (0)
185: Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia – a UK experience (2007) (0)
AUTHORS' REPLY (1990) (0)
P10 Carboplatin and gemcitabine impair neutrophil phagocytic function (2013) (0)
Investigation Of Neutrophil Function In Ipah Patients (2016) (0)
Establishing The Effect Of Targeted Therapies On Diffusing Capacity In Patients With Pulmonary Arterial Hypertension (PAH) (2016) (0)
Pulmonary arterial hypertension: current therapies (2003) (0)
IMPACT OF BASELINE RISK STATUS ON OUTCOMES IN THE REPLACE STUDY (2021) (0)
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension (2019) (0)
Analysis of Risk Assessment Tools in the REPLACE Study (2021) (0)
152: Twenty six years experience of lymphoproliferative disease following lung transplantation (PTLD) (2007) (0)
Commentary (1998) (0)
The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease (2016) (0)
202: The effect of calcineurin inhibitors (CNI) on the release of secretory leucoproteinase inhibitor (SLPI) by lung epithelial cells in the presence of transforming growth factor-beta (TGF-β) (2007) (0)
obstructive airways disease . gravity in patients with chronic weight on exercise against Adverse effect of additional and (0)
91: The Role of Transbronchial Biopsies in the Diagnosis of Obliterative Bronchiolitis: Time for a Re-Evaluation? (2008) (0)
Exhaled nitric oxide (ENO) in pulmonary transplant recipients and the influence of Mycophenolate (MMF) (2001) (0)
The Treatment of Congenital Heart Disease Associated Pulmonary Arterial Hypertension (PAH) with Sildenafil. (2009) (0)
530: Correlation of NT-probrain natriuretic peptide (NT-proBNP) and haemodynamics in patients with pulmonary arterial hypertension (PAH) (2007) (0)
The antimicrobial peptide, human beta defensin-2, in acute rejection after human lung transplantation (2006) (0)
Dose-response study ofinhaled salbutamol powderin chronic airflow obstruction (1983) (0)
Authors' reply (2010) (0)
P30 An evaluation of the use of quality-of-life (qol) scores in pulmonary arterial hypertension (2016) (0)
Enhanced avidity from a multivalent fluorescent antimicrobial peptide enables pathogen detection in a human lung model (2019) (0)
The tolerability and efficacy of total lymphoid irradiation (TLI) in the control of rapidly progressive bronchiolitis obliterans syndrome (2003) (0)
The current state of lung transplantation. Reply (1990) (0)
Cystic fibrosis, lung transplantation and clostridium difficile associated disease (2011) (0)
Organ Transplantation: Long-term management and outcomes (2011) (0)
Application of the REVEAL risk score calculator 2.0 in the CHEST study. (2022) (0)
Do asthma studies really apply to primary and secondary care asthmatics (2001) (0)
Pulmonary transplantation in cystic fibrosis (CF): Second organ dysfunction at 3 years post transplantation (1999) (0)
Transforming growth factor beta (TGF beta) induces cellular senescence in primary bronchial epithelial cells: A possible role in airway remodelling (2007) (0)
Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension (2013) (0)
The role of primary graft dysfunction or recurrent acute rejection episodes in the development of Pseudomonas colonisation after lung transplantation (2006) (0)
Lung function today and tomorrow II P 1203 Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome (2011) (0)
Are Peripheral Blood Neutrophils Dysfunctional In Idiopathic Bronchiectasis (2012) (0)
Reply (1985) (0)
The effect of intra-pulmonary CXC-chemokines in the donor lung on early graft function after lung transplantation (1999) (0)
381: Safe Extension of Ischaemic Time in Lung Transplantation – Where Is the Limit? (2008) (0)
Epithelial cell regulation of immunity in cystic fibrosis (2012) (0)
Appetite suppressants andprimary pulmonary hypertension intheUnited Kingdom (1995) (0)
Recurrent Acute Pulmonary Toxicity and Respiratory Failure Associated with Fludarabine Monophosphate (1997) (0)
Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study (2014) (0)
Clinical features of human pulmonary hypertension (2011) (0)
Understanding The Relationship Between Lung Function Measures And Mortality In The Very Old (2016) (0)
421: Effect of induction therapy on the peripheral blood genomic signature in the LARGO lung transplant study (2007) (0)
CME General Internal Medicine for the Physician - II (2001) (0)
Pepsin detection in the lungs of transplant patients: Evidence of gastric refluxate (2004) (0)
Developing a non-invasive test for pseudomonas detection: towards an electronic nose (2008) (0)
Small airway reticular basement membrane (RBM) thickening in clinically stable lung transplant recipients (SLTR) is not affected by three months treatment with inhaled corticosteroids (ICS) (2002) (0)
Monocyte chemiluminescence in patients with small cell lung cancer (1992) (0)
The effect of nebulised epoprostenol on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease (1999) (0)
The Impact of Air Pollution on Outcome After Lung Transplantation in Europe (2014) (0)
Lipopolysaccharide Structural Profiles Are Not Altered in Genomovar Iii B Cepacia Quorum Sensing Knockouts (2003) (0)
Outcomes of 92 adult CF patients referred to a UK transplant centre; Single centre prognostic modelling (2003) (0)
Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival (2017) (0)
Pregnancy after Lung Transplantation: A Single Center Experience (2013) (0)
Single- and Bilateral Lung Transplantation: Indications, Contraindications, Evaluation, and Requirements for Patients to Be Considered Eligible (2018) (0)
Author Correction: Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood (2022) (0)
bilateral lung transplantation . Respiratory mechanics after heart-lung and (1998) (0)
One year analysis of CMV-PCR surveillance data in lung transplant recipients (2002) (0)
390: Factors influencing survival to lung transplantation in patients with idiopathic pulmonary fibrosis placed on the waiting list 1999–2004 (2006) (0)
Measurement of Unilateral Pulmonary Blood Flow in Patients with Carcinoma of the Bronchus (1984) (0)
Event-Driven Studies and Serious Chronic Diseases: Addressing Placebo, Drug Efficacy, and Treatment Failure in Pulmonary Artery Hypertension (2014) (0)
424: Temporal Patterns of Lung Pepsin Levels in Allografts Suggest Aspiration Is an Ongoing Injury, Which Can Occur Early Following Lung Transplantation (2009) (0)
Cigarette Smoke Drives Human Pulmonary Microvascular Cells To Undergo a Phenotype Transition to Mesenchymal Cells. (2009) (0)
Distribution of y 6 T-cells in the bronchial tree of smokers and non-smokers (0)
Value of 133Xenon Oblique Images in the Reporting of Radionuclide Lung Scans in Patients with Suspected Pulmonary Emboli (1985) (0)
Factors influencing success of achieving lung transplantation in patients with pulmonary fibrosis placed on the waiting list 1999-2004 (2005) (0)
Morphometric comparison of airway remodelling in chronic obstructive pulmonary disease and obliterative bronchiolitis (2009) (0)
Differential cytokine induction profiles by Burkholderia cepacia genomovars is not explained by LPS chemotypes (2001) (0)
Medical Treatment Of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease (2010) (0)
Pulmonary infiltrates following bone marrow transplantation. (1994) (0)
COMPARISON OF MYELOTOXICITY RELATING TO 2 CHEMOTHERAPY REGIMENS FOR SMALL-CELL LUNG-CANCER (SCLC) (1993) (0)
The feasibility of complete withdrawal of oral corticosteroids following lung transplantation (2005) (0)
117: Aspiration in the Immediate Post Lung Transplantation Period (2009) (0)
Genotypic risk factors for the development of the bronchiolitis oblitererans syndrome (BOS) after lung transplantation (2004) (0)
Infection acquired from transplant donor. (1992) (0)
S126 Interleukin-1 Alpha (IL-1α) Released from Injured Lung Epithelium is a Critical Alarmin Driving Activation of a Potent Inflammatory Phenotype in Lung Fibroblasts (2012) (0)
Assessment for pulmonary transplantation. (1993) (0)
501 Ten Year Survival in Incident Cases of Idiopathic Pulmonary Arterial Hypertension (IPAH) in the Modern Era (2011) (0)
Sheila “Glennis” Haworth CBE (2021) (0)
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome (2011) (0)
The Role of Loss-of-Function Mutations on Death and Development of Rejection in HTX/LTX Patients (2016) (0)
Management of heart and lung transplant patients (1998) (0)
Faculty Opinions recommendation of Lung transplantation and coronary artery disease. (2011) (0)
Qualitative and quantitative assessments of aspiration in the immediate post-lung transplantation period (2008) (0)
812 Prospective Evaluation of Alveolar and Bronchiolar C4d Expression in Transbronchial Biopsies from Lung Transplanted Recipients (2012) (0)
Lung transplantation for pulmonary hypertension (2012) (0)
Irish Thoracic Society (1995) (0)
293: Synergistic activities of twelve agents tested as triple combinations against 30 strains of multiresistant Pseudomonas aeruginosa and Burkholderia cepacian isolated pre and post lung transplantation (2007) (0)
Variability in Proinflammatory Activity of B Cepacia Genomovars Lipo-Polysaccharide (Lps); the Role of Lps Structural Differences and Chemotype (2003) (0)
Pulmonary Antimicrobial Peptide Expression in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome (BOS) (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul A. Corris?

Paul A. Corris is affiliated with the following schools:

Newcastle University

Paul A. Corris's Academic­Influence.com Rankings

Why Is Paul A. Corris Influential?

Paul A. Corris's Published Works

Published Works

What Schools Are Affiliated With Paul A. Corris?

Paul A. Corris's AcademicInfluence.com Rankings